COVAC1 phase 2a expanded safety and immunogenicity study of a self-amplifying RNA vaccine against SARS-CoV-2SARS-CoV-2自扩增RNA疫苗的COVAC1 2a期扩大安全性和免疫原性研究ECLINICALMEDICINEIF102023-02-0118OAAI
Enhanced immune responses following heterologous vaccination with self-amplifying RNA and mRNA COVID-19 vaccinesPLOS PATHOGENSIF4.92022-10-048OAAI
SARS- CoV-2 lateral flow assays for possible use in national covid-19 seroprevalence surveys (React 2): diagnostic accuracy studyBMJ-BRITISH MEDICAL JOURNALIF42.72021-03-0242OAAI
Clinical and laboratory evaluation of SARS-CoV-2 lateral flow assays for use in a national COVID-19 seroprevalence surveyTHORAXIF7.72020-08-1288OAAI